Top Section/Ad
Top Section/Ad
Most recent
International tension has propelled valuations in the sector up, tempting issuers
Czech defence firm priced at a discount to German competitor Rheinmetall
Czech defence firm set for largest European IPO since Porsche's 2022 listing
Listing meant to give government fiscal breathing room
More articles/Ad
More articles/Ad
More articles
-
China Resources Mixc Lifestyle Services has begun testing investor appetite for a Hong Kong listing that could raise around $1bn, said a source close to the deal. -
Antengene Corp, a clinical stage biopharmaceutical company, has set its Hong Kong listing in motion. It has opened bookbuilding for an up to HK$2.79bn ($359.4m) IPO.
-
Singapore-based special purpose acquisition company (Spac) Tiga Acquisition Corp has set in motion a $200m listing on the New York Stock Exchange.
-
Chinese video-sharing platform Kuaishou Technology is planning to float in Hong Kong, having filed a draft prospectus with the city’s stock exchange.
-
Antengene Corp, a clinical stage biopharmaceutical company, is set to launch the roadshow for its Hong Kong IPO next week after wrapping up pre-deal investor education, according to a source close to the listing.
-
The Shanghai Stock Exchange stunned the market on Tuesday by halting Ant Group’s $34bn IPO, set to be the largest listing in history, just two days before the company’s planned stock market debut. The extraordinary move is expected to delay the listing by at least six months. It will also force investors to revalue the company, write Jonathan Breen and Addison Gong.
